MedTrace Logo

Effect of Switching From Cigarette Smoking to the Use of IQOS on Periodontitis Treatment Outcome

NCT03364751 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 179

Last updated 2023-01-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to demonstrate in patients with generalized chronic periodontitis that switching from cigarette smoking to using IQOS improves the response to periodontal therapy and the overall oral health status compared to continuing cigarette smoking.

Note: "IQOS" is the Tobacco Heating System (THS) with Marlboro Heatsticks, marketed in Japan under the brand name IQOS

Conditions

  • Periodontal Diseases
  • Chronic Periodontitis
  • Periodontal Pocket
  • Tooth Mobility
  • Gingival Diseases
  • Smoking, Cigarette

Interventions

OTHER

IQOS

Patients will switch from cigarette smoking to ad libitum IQOS use.

OTHER

Cigarette

Patients will continue to smoke cigarettes ad libitum.

Sponsors & Collaborators

  • Philip Morris Products S.A.

    lead INDUSTRY

Principal Investigators

  • Christelle Haziza, PhD · Philip Morris Products S.A.

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-07
Primary Completion
2018-12-21
Completion
2019-06-12

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03364751 on ClinicalTrials.gov